Hong Kong’s pandemic fight shows need to boost R&D, health minister says, outlining plans to turn city into biomedical innovation hub

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Health authorities also considering setting up city’s own drug regulatory approval system, which can lure pharmaceutical firms, Lo Chung-mau says.